29,245
Views
66
CrossRef citations to date
0
Altmetric
Editorial

Broad-Spectrum Antiviral Agents: A Crucial Pandemic Tool

&
Pages 467-470 | Received 12 Mar 2019, Accepted 19 Jun 2019, Published online: 24 Jun 2019
 

Declaration of interest

A Adalja owns stock in Merck and is on an advisory board for their anti-bacterial program. The authors have no other relevant affiliations or financial involvement with any organization or entity with a financial interest in or financial conflict with the subject matter or materials discussed in the manuscript apart from those disclosed.

Reviewer disclosures

A reviewer on this manuscript has disclosed that they are a speaker for Abbvie, Gilead, Merck, and BioTest; an advisor for Abbvie, Gilead, and Merck; research support for Abbvie and Gilead. Peer reviewers on this manuscript have no other relevant financial relationships or otherwise to disclose.

Additional information

Funding

The authors were supported by the Open Philanthropy Foundation.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.